2FEIGIN V L, DORONIN B M, POPOVA T F, et al. Vinpocetine treatment in acute ischaemic stroke. A pilot singleblind randomized clinical trial[J]. Eur J Neurol,2001,8( 1 ) :81-85.
二级参考文献7
1CUIZP.Pharmacological effects and clinical application of vinpocetin .辽宁药物与临床,2002,5(1):68-69.
2SZAKACS T, VERES Z, VERECZKEY L. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine[ J ]. Pol J Pharmacol, 2001,53(6) :623-628.
3PUDLEINER P, VERECZKEY L. Study on the absorption of vinpocetine and apovincaminic acid[ J]. Eur J Drug Metab Pharmacokinet, 1993, 8(4) :317-321.
4MISKOLCZI P, KOZMA K, POLGAR M, et al. Pharmacokinetics of vlnpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans [ J ]. Eur J Drug Metab Pharmacokinet, 1990,15 ( 1 ) : 1-5.
5LAURIAN V. SILVIA I, SORIN L New HPLC-MS method for quantitative determinallon of apovincaminic acid in human plasma [ J ].J Sep Sci, 2006,29 (3) :385-389.
6CHEN J, CU1 J, TAO W X, et al. Determination of apovineaminic aeid in human plasma by high-performanee liquid chromatography using solid-phase extraction and uhraviolet detection [ J]. J Chromatogr B, 2006,18 ( 2 ) :201-206.
7MANUELA T M, JOAO P P, HENRIQUE M A, et al. Determination of apovinc, aminic acid in human plasma by high-performance liquid chromatography[ J ]. J Pharm Biomed Anal, 1996,14(5 ) : 617-622.
